ArticleDiagnostics (Basel, Switzerland)2023
Classification of Parkinson's Disease in Patch-Based MRI of Substantia Nigra.
Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Detection of parkinson's disease with neuroimaging modalities using machine learning and artificial intelligence: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Pooled it
- Spine-anchored active contour-based renal spatial prioritization for precision-constrained volumetric segmentation of bilateral nephric tumors via spine-guided 3D deep encoders in abdominopelvic tomographic data.Radiological physics and technology · 2026Article
- A 19-layer convolutional neural network for accurate COVID-19 detection in chest X-ray images: comparative analysis with pretrained networks.Scientific reports · 2026Article
- White blood cell classification using custom deep neural network and visualizing features of the images using heatmaps.Scientific reports · 2026Article
- An efficient dual path deep learning framework for COVID-19 classification using lung CT scans with explainable AI.Scientific reports · 2026Article
- A quantum-classical dual-track deep learning network for explainable Parkinson's disease classification.Frontiers in artificial intelligence · 2026Article
- Convolutional neural networks in brain disease diagnosis: a unified review of Alzheimer's, Parkinson's, and brain tumor classification.Frontiers in neuroscience · 2026Review
- Optimized CNN framework for malaria detection using Otsu thresholding-based image segmentation.Scientific reports · 2025Article
- Enhanced EfficientNet-Extended Multimodal Parkinson's disease classification with Hybrid Particle Swarm and Grey Wolf Optimizer.Scientific reports · 2025Article
- A swin transformer and CNN fusion framework for accurate Parkinson disease classification in MRI.Scientific reports · 2025Article
- Parkinson's disease detection using spectrogram-based multi-model feature fusion networks.Frontiers in neurology · 2025Article
- Revolutionizing healthcare: a comparative insight into deep learning's role in medical imaging.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 3 countries.
Funding
Abstract
Parkinson's disease (PD) is a chronic and progressive neurological disease that mostly shakes and compromises the motor system of the human brain. Patients with PD can face resting tremors, loss of balance, bradykinesia, and rigidity problems. Complex patterns of PD, i.e., with relevance to other neurological diseases and minor changes in brain structure, make the diagnosis of this disease a challenge and cause inaccuracy of about 25% in the diagnostics. The research community utilizes different machine learning techniques for diagnosis using handcrafted features. This paper proposes a computer-aided diagnostic system using a convolutional neural network (CNN) to diagnose PD. CNN is one of the most suitable models to extract and learn the essential features of a problem. The dataset is obtained from Parkinson's Progression Markers Initiative (PPMI), which provides different datasets (benchmarks), such as T2-weighted MRI for PD and other healthy controls (HC). The mid slices are collected from each MRI. Further, these slices are registered for alignment. Since the PD can be found in substantia nigra (i.e., the midbrain), the midbrain region of the registered T2-weighted MRI slice is selected using the freehand region of interest technique with a 33 × 33 sized window. Several experiments have been carried out to ensure the validity of the CNN. The standard measures, such as accuracy, sensitivity, specificity, and area under the curve, are used to evaluate the proposed system. The evaluation results show that CNN provides better accuracy than machine learning techniques, such as naive Bayes, decision tree, support vector machine, and artificial neural network.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.